Xlife Sciences AG
Overview
Xlife Sciences AG is a Swiss-listed life sciences incubator and accelerator that identifies, develops, and commercializes early-stage research projects from universities and research institutions across technology platforms, biotechnology, medical technology, and artificial intelligence.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| VERAXA Biotech AG | Apr 2025 | M&A | Co-investor |
| 4D Lifetec | Oct 2023 | Early Funding | Lead |
| saniva diagnostics GmbH | Nov 2019 | Seed | Lead |
| novaxomx | Mar 2022 | Joint Venture | Co-investor |
| FUSE-AI | Oct 2019 | Seed | Lead |
For institutional investors. Book with your work email.
Key People
Valery Lorenz
Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Xlife Sciences AG based?
Xlife Sciences AG is headquartered in Zurich, Switzerland.
When was Xlife Sciences AG founded?
Xlife Sciences AG was founded in 2019.
How many portfolio companies does Xlife Sciences AG have?
Xlife Sciences AG has 12 portfolio companies in Caplight's dataset.
What are some companies in Xlife Sciences AG's portfolio?
Portfolio companies visible on Caplight include VERAXA Biotech AG, 4D Lifetec, saniva diagnostics GmbH, novaxomx, FUSE-AI.
What was Xlife Sciences AG's most recent investment shown here?
Xlife Sciences AG's most recent investment in this portfolio sample was in VERAXA Biotech AG in 2025.
What sectors does Xlife Sciences AG focus on?
Xlife Sciences AG focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure.
What company stages does Xlife Sciences AG focus on?
Stage focus information for Xlife Sciences AG is not publicly available.
What is Xlife Sciences AG's AUM?
Xlife Sciences AG's assets under management are estimated between $679.0M and $829.1M.